Aphonie Hair Regrowth Treatment for Men

Manufacturer
Guangdong Jiaoyu Biotechnology Co., Ltd
Effective date
2026-10-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-11-03 06:09:02

Label at a glance#

ProductAphonie Hair Regrowth Treatment for Men
Active ingredientMINOXIDIL
Label structure8 sections

Label contents#

Full prescribing information#

WARNINGS SECTION


Warnings
For external use only. For use by men only.
Flammable: Keep away from fire or flame.
May be harmful if used when pregnant or breast-feeding.
Do not use if:
- you are a woman
- or your hair loss is on the front of the scalp. 5% minoxidil topical solution is not intended for frontal baldness or receding hairline
- you have no family history of hair loss
- your hair loss is sudden and/or patchy
- you do not know the reason for your hair loss
- you are under 18 years of age. Do not use on babies and children
- your scalp is red, inflamed, infected, irritated, or painful
- you use other medicines on the scalp
Ask a doctor before use if you have heart disease.
When using this product:
- do not apply on other parts of the body
- avoid contact with the eyes. In case of accidental contact, rinse eyes with large amounts of cool tap water
- some people have experienced changes in hair color and/or texture
- it takes time to regrow hair. Results may occur at 2 months with twice a day usage
- for some men, you may need to use this product for at least 4 months before you see results
- the amount of hair regrowth is different for each person. This product will not work for all men
Stop use and ask a doctor if:
- chest pain, rapid heartbeat, faintness, or dizziness occurs
- sudden, unexplained weight gain occurs
- your hands or feet swell
- scalp irritation or redness occurs
- unwanted facial hair growth occurs
- you do not see hair regrowth in 4 months

INACTIVE INGREDIENT SECTION

ALCOHOL
BIOTIN
ASIAN GINSENG
DEXPANTHENOL
PROPYLENE GLYCOL
WATER

INDICATIONS & USAGE SECTION

To regrow hair on the top of the scalp (vertex only).

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

OTC - PURPOSE SECTION

Hair regrowth treatment for men.

RECENT MAJOR CHANGES SECTION

Apply one mL (6 sprays) 2 times a day directly onto the scalp in the hair loss area. Using more or more often will not improve results. Continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again.

DOSAGE & ADMINISTRATION SECTION


Apply one mL (6 sprays) 2 times a day directly onto the scalp in the hair loss area. Using more or more often will not improve results. Continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1 11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87722-41387722-413-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
MINOXIDIL5965120SH1ACTIB
ALCOHOL3K9958V90MIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Aphonie Hair Regrowth Treatment for MenMINOXIDILGuangdong Jiaoyu Biotechnology Co., Ltd5ee65548-5e64-0fa9-e063-6294a90a42cb2026-10-28WarningsExact identifier
ndc (package): 87722-413-01
ndc (product): 87722-413
ndc11 (package): 87722041301
spl id: 5ee65554-1383-0fd8-e063-6294a90a31e3
spl set id: 5ee65548-5e64-0fa9-e063-6294a90a42cb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.